Neal Walker, President and CEO at Aclaris Therapeutics, Inc. (ACRS), sold 3,595 shares at $12.66 ($46K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Seasonal sale ($46k) by President and CEO — this insider has traded ACRS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |